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The quest for the function of BPAG1, a major
hemidesmosomal protein of skin keratinocytes, has led
to the discovery of a group of protein isoforms derived
from the same genomic locus that are involved in
organizing and integrating cytoskeletal networks in
sensory neurons.
Address: Departments of Biological Chemistry and Dermatology, The
Johns Hopkins University School of Medicine, 725 North Wolfe Street,
Baltimore, Maryland 21205, USA.
Correspondence to: Pierre A. Coulombe.
E-mail: pacoulom@welchlink.welch.jhu.edu
Current Biology 1996, Vol 6 No 12:1563–1566
© Current Biology Ltd ISSN 0960-9822
Often, straightforward experiments give rise to totally
unexpected outcomes. Fuchs and her colleagues [1] expe-
rienced this in the form of a dramatic neurological pheno-
type in mice carrying a homozygous disruption of a gene
whose product was known to be a component of
hemidesmosomes in epithelial cells. Recent work from the
same group [2] now provides an explanation for this puz-
zling occurrence, and identifies a group of protein isoforms
that function to link distinct types of fibrous protein poly-
mers into an integrated cytoskeleton. Here, we summarize
how these and other recent studies provide an emerging
picture of how various cell types evolve a cytoarchitecture
that suits their differentiated function, using related
protein building blocks. 
This story begins with the epidermis, a stratified
squamous epithelium located at the skin surface that acts
as the primary determinant of the skin’s vital barrier func-
tion. Epidermal keratinocytes achieve a flexible and
highly resilient cytoarchitecture in part by building a
prominent cytoskeletal framework composed primarily of
keratin-based intermediate filaments. Intermediate fila-
ments are long and flexible, 10–12 nm diameter, and are
ubiquitous in the cells of higher multicellular eukaryotes.
They can be assembled from more than 50 distinct pro-
teins, which are heterogeneous in several respects but
which can be grouped into distinct types on the basis of
gene structure and sequence homology [3]. 
Type I–IV intermediate filament proteins localize to the
cytoplasm of specific cell types, where they are organized
into a filamentous network that spans nearly the entire cell,
independent of the cell’s degree of spatial differentiation
— whether a lymphocyte or a neuron. The intermediate
filaments of epithelial cells are co-polymers of type I and
type II keratins that extend radially and in a non-polarized
fashion from the nucleus to the plasma membrane, where
they interact with macromolecular complexes that mediate
cell–cell and cell–matrix adhesion. In stratified epithelia,
these complexes are desmosomes, which form cell–cell
junctions, and hemidesmosomes, integrin-based mediators
of the attachment of basal keratinocytes to the basal
lamina. Given their anchorage at hundreds of points of
contact, keratin intermediate filaments seem to be inte-
grated within a supracellular network that is likely to
underlie the vital properties of resilience and flexibility in
stratified epithelia. The discovery that inherited mutations
that affect specific keratins, and thereby compromise
keratin filament integrity, cause a variety of inherited skin
blistering diseases established that an integral intermediate
filament network is indeed an essential determinant of the
ability of the epidermis to cope with the mechanical
stresses it routinely endures (see [4]). 
BPAG1, the bullous pemphigoid antigen 1, is a 230 kDa
protein that was initially characterized as a major auto-
antigen in patients suffering from bullous pemphigoid [5].
This late-onset bullous disease affects the skin and mucous
membranes, and is characterized by the presence of circu-
lating autoantibodies directed against hemidesmosome-
associated antigens. Immunoelectron microscopy showed
that BPAG1 localizes mainly to the cytoplasmic ‘plaque’
domain of hemidesmosomes, at the site of keratin interme-
diate filament anchorage [5]. The tail domain of BPAG1 is
homologous to that of desmoplakin, a major component of
the cytoplasmic domain of desmosomes, and to that of
plectin, an intermediate-filament binding protein present in
both desmosomes and hemidesmosomes. Given that
desmoplakin and plectin tails can both associate with
keratin filaments in vivo and in vitro [6–8], it seemed likely
that BPAG1 could be directly involved in linking keratin-
containing intermediate filaments to hemidesmosomes. 
To test this notion, Guo et al. [1] introduced a null muta-
tion in the mouse BPAG1 gene. Consistent with the postu-
late, absence of BPAG1 protein in basal keratinocytes
resulted in the loss of the inner cytoplasmic plaque and
‘severing’ of keratin filaments at hemidesmosomes. The
BPAG1-null mice displayed a typical blistering phenotype
upon incident mechanical trauma to the skin, and cleavage
of the epidermis took place in a narrow region of cyto-
plasm beneath the keratinocyte plasma membrane domain
abutting the basal lamina [1]. This experiment thus
demonstrated an essential role for BPAG1 in anchoring
keratin intermediate filaments at hemidesmosomes, and
showed this interaction to be essential for the structural
integrity of stratified epithelia such as the epidermis,
tongue and oral mucosa.
Most unexpectedly, the BPAG1-null mice also showed
severe neurodegeneration and dystonia typical of dystonia
musculorum (dt/dt) mice. In various strains of dt/dt as well as
in BPAG1-null mice, a selective sensory neuropathy leads
to a progressive deterioration of motor function, starting at
7–10 days postnatally and culminating in death a few
weeks later (see [1,9]). Yet the BPAG1 protein, as con-
ceived of by epithelial biologists, does not occur in nervous
tissue. On the other hand, Guo et al. [1] found the BPAG1
protein to be missing in the stratified epithelia of one of
two spontaneous dt/dt strains they examined (dt/dtalb). How
is this possible? A solution to the paradox was provided by
Kothary and his colleagues [9], who exploited a line of
transgenic mice, tg4, which carry a large insertional muta-
tion at the dt locus, to characterize the corresponding wild-
type gene. They isolated partial sequences for two mRNA
transcripts that span the tg4 deletion site and contain
sequences corresponding to exon 2 of the ‘epithelial
BPAG1 gene’ (which has a total of 22 exons; see [10]). 
As might be predicted from the dt phenotype, the tg4-
spanning BPAG1 transcripts are present in the dorsal root
and trigeminal ganglia, as detected by in situ hybridization
(see also [2]). From the available data on the ‘epithelial
BPAG gene’ [10] and their own results, Khotary and col-
leagues [9] proposed a model that accounts for the produc-
tion of neuron-specific and epithelium-specific transcripts
from a single gene, the dt/BPAG1 locus, as a result of the
use of alternative promoters and a combination of isoform-
specific and shared exons (Fig. 1). In addition, they recog-
nized the presence of a potential actin-binding domain
(ABD) in the amino-terminal segment of the two BPAG1
neuronal isoforms; this domain is predicted to be missing
in the epithelial isoform. Fuchs and colleagues [2] recently
completed the cloning and extended the characterization
of the neuronal-specific BPAG1 cDNA sequences; they
proposed the designation BPAG1e and BPAG1n for the
epithelial and neuronal isoforms, respectively. The pro-
posed transcript map shown in Figure 1 accounts for the
phenotypes associated with the BPAG1-null mutation and
the various strains of dt/dt mice [1,2,9]. 
The presence of a potential actin-binding domain in both
BPAG1n isoforms leads to the prediction that they could
mediate an interaction between neuronal intermediate fil-
aments (neurofilaments) and actin microfilaments in the
subset of sensory neurons expressing them. This predic-
tion is supported by several lines of evidence, not least
being the disruption of neurofilaments in the axoplasm of
the BPAG1n-expressing sensory neurons of dt/dt mice (see
[2,9] and references therein). The Fuchs laboratory [2]
provided compelling evidence in support of the ‘linker’
hypothesis in an elegant set of follow-up studies. They
showed that transfection of the amino-terminal domain
characteristic of BPAG1n isoforms (containing the ABD
motif) in human SCC13 keratinocytes results in its co-
localization with endogenous microfilaments, and that this
interaction can be reproduced in vitro using purified com-
ponents. They also showed that the tail domain of
BPAG1e/n colocalizes with endogenous keratin filaments
in transfected keratinocytes, and that it colocalizes with
neurofilaments when co-transfected with neurofilament
cDNAs in a SW13 cell clone totally lacking in intermedi-
ate filaments. Finally, they showed that co-transfection of
a full-length BPAG1n cDNA and neurofilament cDNAs
in intermediate-filament-negative SW13 cells resulted in
frequent co-alignment of the immunofluorescence signals
for BPAG1, neurofilaments and microfilaments.
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Figure 1
(a) Schematic representation of the proposed organization of the
BPAG1 genomic locus (adapted from [9]). Two tissue-specific
promoters direct the expression of neuron-specific (BPAG1n1,
BPAG1n2) and epithelium-specific (BPAG1e) isoform mRNAs. Two
neuronal isoforms are predicted to arise from the alternative splicing of a
precursor mRNA. (b) Schematic representation of the BPAG1 protein
isoforms (adapted from [2]). Regions are color-coded to highlight their
origin with respect to the genomic locus: green boxes, neuronal isoform-
specific coding sequences; yellow, actin-binding domain (ABD), which is
also specific to the neuronal isoforms; blue, sequences corresponding to
exon 1 of the BPAG1e coding unit and specific for the epithelial isoform;
pink, sequences corresponding to exon 2 of the BPAG1e coding unit,
which mark the beginning of the shared sequences between all
isoforms; orange, coding sequences shared by all isoforms and
containing the intermediate-filament binding site(s). An additional isoform
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These studies demonstrated that, in a living cell context,
BPAG1n can not only bind to microfilaments and neurofila-
ments simultaneously, but also force their merging into an
integrated structure [2]. The BPAG1n isoforms may thus
contribute to defining the cytoarchitecture of the axoplasm
by tethering parallel arrays of densely packed neurofila-
ments to the microfilament cytoskeleton. If proven, this
would imply that the neuronal and epithelial isoforms of
BPAG1 both contribute directly to the organization of an
integrated cytoskeleton adapted to the structural and func-
tional requirements of the cell types in which they are each
expressed. Meanwhile, the functional implications of a neu-
rofilament–microfilament interaction for the biology of
sensory neurons need to be further investigated. Moreover,
whether this interaction occurs in all type of neurons, and if
so, the identity of the connector protein(s) that could
mediate an intermediate filament–microfilament interaction
in the extensive population of neurons that apparently lack
BPAG1, are now important issues open for investigation. 
The recent work from Fuchs and colleagues reinforces the
notion that BPAG1e/n, desmoplakin and plectin belong to
a family of structurally and functionally related proteins
[11] that serve as linkers between cytoplasmic intermedi-
ate filaments and various types of cytoskeletal and adhe-
sion-mediating protein polymers. Plectin is unique among
cytoskeletal connector proteins because it displays bio-
chemical properties that potentially enable it to pro-
foundly affect the organization of all three major types of
cytoplasmic filaments — intermediate filaments, microfil-
aments and microtubules (see [12–14]). Recent studies on
plectin yielded additional evidence of its relatedness to
BPAG1. For instance, the amino-terminus of plectin fea-
tures an amino-acid sequence highly homologous to the
actin-binding domain of BPAG1n [2], and Wiche and col-
leagues [12] provided ultrastructural evidence for the exis-
tence of plectin-based cross-bridges between
vimentin-containing intermediate filaments and microfila-
ments in rat C6 glioma cells. The same group recently
identified a 50 amino-acid segment in the tail domain of
plectin that is capable of binding vimentin and keratin fil-
aments in vitro and in vivo [13]. This segment features a
basic motif at its amino-terminal end that is not only
essential for intermediate filament binding but also
capable of acting as a nuclear localization signal (the sig-
nificance of this surprising finding remains unclear).
Wiche and colleagues [13] also pointed out that they
obtained evidence for additional intermediate filament-
binding sites on the plectin molecule. Whether plectin,
BPAG1e/n and desmoplakin bind intermediate filaments
by the same mechanism(s) remains to be determined. 
At another level, a frameshift mutation in the coding
sequence of plectin was recently shown to cause epider-
molysis bullosa (EB) with muscular dystrophy [15]; EB is
the collective name for a group of inherited skin bullous
diseases (see [4]). It is likely that mutations in the plectin
gene underlie yet another form of EB, called EBS-Ogna,
as both map to 8q24 [14]. Given the similarities at multi-
ple levels, including their ability to bind both intermedi-
ate filaments and microfilaments, their subcellular
localization and their association with related types of
human disease, it seems very likely that the plectin and
BPAG1 isoforms perform related functions in vivo.
The discovery of multiple BPAG1 isoforms arising from
the alternative, tissue-specific splicing of a precursor
mRNA provides a further similarity to plectin and desmo-
plakin. Two desmoplakin isoforms have been described
that are predicted to arise from the alternative splicing of
5′ exons in a precursor mRNA [16], and evidence that a
similar situation may hold for plectin has recently
emerged [14,15]. If confirmed, the existence of alternative
splice isoforms for plectin would provide a likely explana-
tion for some conflicting data concerning the sequence
and subcellular localization of this protein.
The cytoskeleton forms an intricate three-dimensional web
that is an intrinsic determinant of the functional organiza-
tion of eukaryotic cells. Ever since the first model attempt-
ing to merge the three major types of cytoplasmic filaments
(microfilaments, microtubules and intermediate filaments)
into an integrated three-dimensional structure [17], direct
evidence supporting such an integrated cytoskeleton and,
in particular, information relative to the molecules responsi-
ble for integration have proven elusive. The recent results
with plectin and BPAG1 isoforms have finally yielded proof
of the existence and essential nature of such ‘missing links’.
Continued studies of BPAG1, plectin, desmoplakin and
related molecules will undoubtedly provide further evi-
dence of their coalition as a group of structurally and func-
tionally related proteins responsible for the dynamic
organization of an integrated cytoskeleton. Such studies are
also likely to provide clues as to how the corresponding
genes may have evolved in parallel with the intermediate
filament gene family (and by extension, other cytoskeletal
proteins) to tailor the cytoskeleton for the general as well as
the specialized needs of differentiated cell types.
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